Similarly, several studies have shown that AIFM2 represents an unfavorable prognostic factor in prostate cancer, acute myeloid leukemia and uveal melanoma (Luo and Ma, 2021; Lv et al., 2021; Song et al., 2021). This evidence concerns the gene AIFM2 and prostate cancer.